日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

During HCV DAA Therapy Plasma Mip1B, IP10, and miRNA Profile Are Distinctly Associated with Subsequent Diagnosis of Hepatocellular Carcinoma: A Pilot Study

在HCV DAA治疗期间，血浆Mip1B、IP10和miRNA谱与后续肝细胞癌的诊断显著相关：一项初步研究

期刊:Biology-Basel
影响因子:3.5
doi:10.3390/biology11091262
Damjanovska, Sofi; Alao, Hawwa; Zebrowski, Elizabeth; Kowal, Corinne; Kostadinova, Lenche; Davitkov, Perica; Falck-Ytter, Yngve; Shive, Carey L; Cartwright, Michael; Richardson, Brian; Wald, David; Cameron, Mark; Valadkhan, Saba; Anthony, Donald D
miRNA
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Soluble Markers of Immune Activation Differentially Normalize and Selectively Associate with Improvement in AST, ALT, Albumin, and Transient Elastography During IFN-Free HCV Therapy.

在无干扰素 HCV 治疗期间，免疫激活的可溶性标志物可差异性地正常化，并选择性地与 AST、ALT、白蛋白和瞬时弹性成像的改善相关

期刊:Pathogens and Immunity
影响因子:
doi:10.20411/pai.v3i1.242
Kostadinova Lenche, Shive Carey L, Zebrowski Elizabeth, Fuller Brianna, Rife Kelsey, Hirsch Amy, Compan Anita, Moreland Anita, Falck-Ytter Yngve, Popkin Daniel L, Anthony Donald D
其它
发表日期：2018
文献求助 收藏